Gladstone opens institutes to study unsolved diseases

By The Science Advisory Board staff writers

May 8, 2020 -- Gladstone Institutes plans to launch two new biomedical research institutes in San Francisco to broaden its impact on unsolved diseases, including COVID-19.

Under the leadership of Dr. Melanie Ott, Gladstone Institute of Virology will study COVID-19 and study novel therapies against future infectious diseases. Researchers will focus on the way viruses interact with human host cells to cause disease and how to intervene in that process.

The other facility, which is a partnership between Gladstone and the University of California, San Francisco (UCSF), is the Gladstone-UCSF Institute of Genomic Immunology. Led by Dr. Alexander Marson, this facility will work to better understand the genetic control of human immune cells and develop novel cell-based immunotherapies.

Copyright © 2020
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here